Abstract
ALK1 (ACVRL1) is a member of the TGFβ receptor family and is expressed predominantly by arterial endothelial cells (EC). Mutations in ACVRL1 are responsible for hereditary hemorrhagic telangiectasia type 2 (HHT2), a disease manifesting as fragile vessels, capillary overgrowth, and numerous arterio-venous malformations. Arterial EC also express EphrinB2, which has multiple roles in vascular development and angiogenesis and is known to be reduced in ACVRL1 knockout mice. Using an in vitro angiogenesis model we find that the Alk1 ligand BMP9 induces EphrinB2 in EC, and this is entirely dependent on expression of Alk1 and at least one of the co-receptors BMPRII or ActRII. BMP9 induces both ID1 and ID3, and both are necessary for full induction of EphrinB2. Loss of Alk1 or EphrinB2 results in increased arterial-venous anastomosis, while loss of Alk1 but not EphrinB2 results in increased VEGFR2 expression and enhanced capillary sprouting. Conversely, BMP9 blocks EC sprouting and this is dependent on Alk1, BMPRII/ActRII and ID1/ID3. Finally, notch signaling overcomes the loss of Alk1—restoring EphrinB2 expression in EC, and curbing excess sprouting. Thus, in an in vitro model of HHT2, loss of Alk1 blocks BMP9 signaling, resulting in reduced EphrinB2 expression, enhanced VEGFR2 expression, and misregulated EC sprouting and anastomosis.
Similar content being viewed by others
References
HHT Foundation International website (2011)
Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24(6):203–219
Govani FS, Shovlin CL (2009) Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17(7):860–871. PMCID: 2986493
Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189–195
McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345–351
Barbara NP, Wrana JL, Letarte M (1999) Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 274(2):584–594
Blanco FJ, Santibanez JF, Guerrero-Esteo M, Langa C, Vary CP, Bernabeu C (2005) Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex. J Cell Physiol 204(2):574–584
Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW et al (2009) Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Invest 119(11):3487–3496. PMCID: 2769195
Bonyadi M, Rusholme SA, Cousins FM, Su HC, Biron CA, Farrall M et al (1997) Mapping of a major genetic modifier of embryonic lethality in TGF beta 1 knockout mice. Nat Genet 15(2):207–211
Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M (2001) Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 158(6):2011–2020. PMCID: 1891990
Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682–689
David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20(3):203–212
David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S et al (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102(8):914–922
David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109(5):1953–1961
Holderfield MT, Hughes CC (2008) Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Circ Res 102(6):637–652
Brown MA, Zhao Q, Baker KA, Naik C, Chen C, Pukac L et al (2005) Crystal structure of BMP-9 and functional interactions with pro-region and receptors. J Biol Chem 280(26):25111–25118
Pardali E, Goumans MJ, ten Dijke P (2010) Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20(9):556–567
Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z et al (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111(2):633–642. PMCID: 2200847
Seki T, Hong KH, Oh SP (2006) Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development. Lab Invest A J Tech Methods Pathol 86(2):116–129
Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21(7):1743–1753
Lamouille S, Mallet C, Feige JJ, Bailly S (2002) Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100(13):4495–4501
Lux A, Salway F, Dressman HK, Kroner-Lux G, Hafner M, Day PJ et al (2006) ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression. BMC Cardiovasc Disord 6:13
Mallet C, Vittet D, Feige JJ, Bailly S (2006) TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24(11):2420–2427
Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H et al (2002) Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells. J Cell Physiol 193(3):299–318
Goumans MJ, Lebrin F, Valdimarsdottir G (2003) Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 13(7):301–307
Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK et al (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Nat Acad Sci USA 97(6):2626–2631
Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Lekven AC et al (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129(12):3009–3019
Scharpfenecker M, van Dinther M, Liu Z, van Bezooijen RL, Zhao Q, Pukac L et al (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120(Pt 6):964–972
Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26(3):328–331
Upton PD, Davies RJ, Trembath RC, Morrell NW (2009) Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J Biol Chem 284(23):15794–15804. PMCID: 2708876
Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM et al (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230(2):151–160
Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G et al (2001) Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230(2):139–150
Krebs LT, Starling C, Chervonsky AV, Gridley T (2010) Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis 48(3):146–150. PMCID: 2849749
Bochenek ML, Dickinson S, Astin JW, Adams RH, Nobes CD (2010) Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding. J Cell Sci 123(Pt 8):1235–1246. PMCID: 2848112
Heroult M, Schaffner F, Pfaff D, Prahst C, Kirmse R, Kutschera S et al (2010) EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinb2. Mol Cancer Res MCR 8(10):1297–1309
Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T et al (2010) Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465(7297):487–491
Wang Y, Nakayama M, Pitulescu ME, Schmidt TS, Bochenek ML, Sakakibara A et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465(7297):483–486
Nakatsu MN, Sainson RC, Aoto JN, Taylor KL, Aitkenhead M, Perez-del-Pulgar S et al (2003) Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1 small star, filled. Microvasc Res 66(2):102–112
Kim JH, Zhao Y, Pan X, He X, Gilbert HF (2009) The unfolded protein response is necessary but not sufficient to compensate for defects in disulfide isomerization. J Biol Chem 284(16):10400–10408. PMCID: 2667727
Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O’Reilly R et al (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts [see comments]. Nature 401(6754):670–677
Sainson RC, Aoto J, Nakatsu MN, Holderfield M, Conn E, Koller E et al (2005) Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J 19(8):1027–1029
Newman AC, Nakatsu MN, Chou W, Gershon PD, Hughes CC (2011) The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Mol Biol Cell 22(20):3791–3800. PMCID: 3192859
David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213(2):484–489
Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U et al (1999) Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13(3):295–306
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163–1177
Henderson AM, Wang SJ, Taylor AC, Aitkenhead M, Hughes CC (2001) The basic helix-loop-helix transcription factor HESR1 regulates endothelial cell tube formation. J Biol Chem 276(9):6169–6176
Holderfield MT, Henderson Anderson AM, Kokubo H, Chin MT, Johnson RL, Hughes CC (2006) HESR1/CHF2 suppresses VEGFR2 transcription independent of binding to E-boxes. Biochem Biophys Res Commun 346(3):637–648
Taylor KL, Henderson AM, Hughes CC (2002) Notch Activation during Endothelial Cell Network Formation in Vitro Targets the Basic HLH Transcription Factor HESR-1 and Downregulates VEGFR-2/KDR Expression. Microvasc Res 64(3):372–383
Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ et al (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci 102(28):9884–9889. PMCID: 1175015
Leblanc GG, Golanov E, Awad IA, Young WL (2009) Biology of vascular malformations of the brain. Stroke 40(12):e694–e702. PMCID: 2810509
Swift MR, Weinstein BM (2009) Arterial-venous specification during development. Circ Res 104(5):576–588
ZhuGe Q, Zhong M, Zheng W, Yang GY, Mao X, Xie L et al (2009) Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain 132(Pt 12):3231–3241. PMCID: 2792368
Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16(2):209–221
Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS (2003) Vascular morphogenesis: tales of two syndromes. Hum Mol Genet 12 Spec No 1:R97–R112
Morikawa M, Koinuma D, Tsutsumi S, Vasilaki E, Kanki Y, Heldin CH et al (2011) ChIP-seq reveals cell type-specific binding patterns of BMP-specific Smads and a novel binding motif. Nucleic Acids Res 39(20):8712–8727. PMCID: 3203580
Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, Pekkan K et al (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138(8):1573–1582. PMCID: 3062425
Suzuki Y, Ohga N, Morishita Y, Hida K, Miyazono K, Watabe T (2010) BMP-9 induces proliferation of multiple types of endothelial cells in vitro and in vivo. J Cell Sci 123(Pt 10):1684–1692
Davidson TM, Olitsky SE, Wei JL (2010) Hereditary hemorrhagic telangiectasia/avastin. The Laryngoscope 120(2):432–435
Acknowledgments
This work was supported by a grant from the HHT Foundation International (CCWH) and an NIH R01 Award (HL60067–CCWH), and an NIH RC1 Award (ES018361–SCG). We thank Dr. Paul Oh for the kind gift of Alk1 plasmids. We thank Linda Him and Matt Peacock for outstanding help with tissue culture.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
10456_2012_9277_MOESM1_ESM.tiff
Fig. S1 ECFC-EC have a phenotype between HUAEC and HUVEC HUAEC, ECFC-EC and HUVEC were grown under identical conditions and then harvested for analysis of artery (EphrinB2) and vein (EphB4, COUP-TFII) markers by qRT-PCR (TIFF 2703 kb)
10456_2012_9277_MOESM2_ESM.tiff
Fig. S2 Alk1 and notch independently regulate angiogenic sprouting A. HUAEC were transfected with expression plasmids for CA-Alk1 or control, established in a sprouting assay and treated with vehicle or 3 μM DAPT. Sprouting was assessed after 5 days by counting tip cells. B. HUAEC were transfected with siRNA to Alk1 or control, and a day later transfected with an expression plasmid encoding dll4, or with a control plasmid. Cells were then seeded in a sprouting assay and sprouts/bead assessed at day 5. (TIFF 2703 kb)
10456_2012_9277_MOESM3_ESM.tiff
Fig. S3 BMP9 suppresses sprouting induced by a loss of notch signaling A. HUAEC were established in a sprouting assay and treated with DAPT and/or BMP9 as indicated. Sprouting was assessed after 5 days by counting tip cells (TIFF 2703 kb)
10456_2012_9277_MOESM4_ESM.tiff
Fig. S4 Multiple BMP response elements in the EphrinB2 promoter Approximately 1 kb of the human EphrinB2 promoter (-900 to +100 bp) was analyzed. The RBPj site is shown in purple, the nine BMP-response elements in green, and the transcription start site is indicated in yellow (TIFF 2703 kb)
10456_2012_9277_MOESM5_ESM.tiff
Fig. S5 At least one conserved BMP response element in the EphrinB2 promoter in multiple species Overlapping regions of the EphrinB2 promoter were aligned from multiple species. At least one site was well conserved between them all – 6/6 residues conserved between human, chimpanzee, chicken and zebrafish, and 5/6 conserved with mouse (TIFF 2703 kb)
Rights and permissions
About this article
Cite this article
Kim, JH., Peacock, M.R., George, S.C. et al. BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Angiogenesis 15, 497–509 (2012). https://doi.org/10.1007/s10456-012-9277-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10456-012-9277-x